• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
MNOV

MNOV

MediciNova, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.32

-0.02 (-1.49%)

Rating:B-

Company Profile

CEO

Yuichi Iwaki

IPO Date

2006-12-08

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.32

Prev. Close

$1.34

Day Low

$1.32

Day High

$1.37

52W Low

$1.17

52W High

$1.96

Market Cap

$0.06B

Volume

0.03M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

30.6%

Avg Negative

1.6%

Avg Neutral

67.7%

News Feed

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Ophthalmic Disease

GlobeNewsWire·7/6/2021·↑ positive

MediciNova to Present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference

GlobeNewsWire·6/29/2021·↑ positive

MediciNova To Test Ibudilast In BARDA's Validated Mouse Model Of Chlorine-Induced Pulmonary Injury

Benzinga·6/28/2021·↑ positive

MediciNova to Conduct Mouse Study under Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury

GlobeNewsWire·6/28/2021·↑ positive

MediciNov Sees Volume After Zacks Research Raises Price Target To $28

Benzinga·6/22/2021·↑ positive

Hot Reddit Penny Stocks to Buy? 10 That You Should Know About

PennyStocks·6/21/2021·↑ positive

MNOV Stock Price Increases Over 30%: Why It Happened

Pulse2·6/21/2021·↑ positive

MediciNova Announces Positive Results from Phase 2 Trial of MN-166 (ibudilast) in Alcohol Use Disorder Published in Nature's Translational Psychiatry Journal

GlobeNewsWire·6/21/2021·↑ positive

MediciNova to Participate in Maxim Group LLC Fireside Chat

GlobeNewsWire·6/14/2021·↑ positive

MediciNova Initiates Sheep Study under Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury

GlobeNewsWire·6/7/2021·↑ positive